Table 7 Concentrations of inhibitors for the combination treatment to AML cells
From: Combination strategies to overcome drug resistance in FLT+ acute myeloid leukaemia
|  | Gilteritinib (nM) | Abemaciclib (µM) |
|---|---|---|
MOLM-13 | 0.26 | 0.04 |
MOLM-14 | 1.67 | 0.02 |
MV4-11 | 1.08 | 1.53 |